Evidence map›Paper›PMID 27841304›Full record

ArticleScientific reports2016

TRF1 phosphorylation on T271 modulates telomerase-dependent telomere length maintenance as well as the formation of ALT-associated PML bodies.

Angus Ho, Florence R Wilson, Stephanie L Peragine, Kajaparan Jeyanthan, Taylor R H Mitchell, Xu-Dong Zhu

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Diagnosis and treatment of ALT tumors: is Trabectedin a new therapeutic option?Journal of experimental & clinical cancer research : CR · 2017
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Angus HoDepartment of Biology, McMaster University, Hamilton, Ontario L8S 4K1, Canada.
Florence R WilsonDepartment of Biology, McMaster University, Hamilton, Ontario L8S 4K1, Canada.
Stephanie L PeragineDepartment of Biology, McMaster University, Hamilton, Ontario L8S 4K1, Canada.
Kajaparan JeyanthanDepartment of Biology, McMaster University, Hamilton, Ontario L8S 4K1, Canada.
Taylor R H MitchellDepartment of Biology, McMaster University, Hamilton, Ontario L8S 4K1, Canada.
Xu-Dong ZhuDepartment of Biology, McMaster University, Hamilton, Ontario L8S 4K1, Canada.
McMaster University · CA

Funding

CIHR MOP-86620
6 · The paper itself

Abstract

TRF1, a component of the shelterin complex, plays a key role in both telomerase-dependent telomere maintenance and alternative lengthening of telomeres, the latter also known as ALT. Characteristics of ALT cells include C-circles and ALT-associated PML bodies, referred to as APBs. The function of TRF1 is tightly regulated by post-translational modification including phosphorylation, however TRF1 phosphorylation sites have yet to be fully characterized. Here we report a novel TRF1 phosphorylation site threonine 271. We show that a nonphosphorylatable mutation of T271A impairs TRF1 binding to telomeric DNA in vivo and renders TRF1 defective in inhibiting telomerase-dependent telomere elongation. On the other hand, TRF1 carrying a phosphomimic mutation of T271D is competent in not only binding to telomeric DNA but also inhibiting telomerase-mediated telomere lengthening. These results suggest that TRF1 phosphorylation on T271 negatively regulates telomerase-mediated telomere maintenance. We find that in telomerase-negative ALT cells, TRF1 carrying either a T271A or T271D mutation is able to promote C-circle production but fails to support APB formation. These results suggest that TRF1 phosphorylation on T271 is necessary for APB formation but dispensable for C-circle production. These results further imply that APB formation can be mechanistically separated from C-circle production.

Indexed as

Cell Line, TumorHeLa CellsHomeostasisHumansIntranuclear Inclusion BodiesMutationPhosphorylationPromyelocytic Leukemia ProteinProtein BindingTelomeraseTelomereTelomere HomeostasisTelomeric Repeat Binding Protein 1TyrosinePML protein, humanPromyelocytic Leukemia ProteinTelomeraseTelomeric Repeat Binding Protein 1Tyrosine

Identifiers

PMID27841304
PMCPMC5107961
OpenAlexW2551319085

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.